Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Metallomics

• Publication date

  2013-01-30

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1039/c2mt20164jPMID 23322189
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• M30, a brain permeable multitarget neurorestorative drug in post nigrostriatal dopamine neuron lesion of parkinsonism animal models.

  2012cited by this paper
• A Mechanistic Study of Proteasome Inhibition-Induced Iron Misregulation in Dopamine Neuron Degeneration

  2012cited by this paper
• Copper complexes as therapeutic agents.

  2012cited by this paper
• Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice.

  2012cited by this paper
• Quantitative imaging of Cu, Fe, Mn and Zn in the L-DOPA-treated unilateral 6-hydroxydopamine Parkinson's disease mouse model by LA-ICP-MS

  2012cited by this paper
• Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export

  2012cited by this paper
• A mutant light-chain ferritin that causes neurodegeneration has enhanced propensity toward oxidative damage.

  2012cited by this paper
• Element imaging in formalin fixed slices of human mesencephalon

  2011cited by this paper
• Ceruloplasmin Oxidation, a Feature of Parkinson's Disease CSF, Inhibits Ferroxidase Activity and Promotes Cellular Iron Retention

  2011cited by this paper
• Metal Ionophore Treatment Restores Dendritic Spine Density and Synaptic Protein Levels in a Mouse Model of Alzheimer's Disease

  2011cited by this paper
• Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson’s disease after peripheral administration

  2011cited by this paper
• Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson’s disease

  2011cited by this paper
• Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

  2011cited by this paper
• ParkDB: a Parkinson’s disease gene expression database

  2011cited by this paper
• Ceruloplasmin Protects Against Rotenone-Induced Oxidative Stress and Neurotoxicity

  2011cited by this paper
• Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent

  2010cited by this paper
• Protective effects of heme oxygenase-1 against MPP+-induced cytotoxicity in PC-12 cells

  2010cited by this paper
• Microglia activation is related to substantia nigra echogenicity

  2010cited by this paper
• Copper binding regulates intracellular alpha‐synuclein localisation, aggregation and toxicity

  2010cited by this paper
• Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson's disease.

  2010cited by this paper
• Proteasome inhibition modeling nigral neuron degeneration in Parkinson’s disease

  2010cited by this paper
• VTA neurons show a potentially protective transcriptional response to MPTP.

  2010cited by this paper
• Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease.

  2010cited by this paper
• Different Susceptibility to the Parkinson's Toxin MPTP in Mice Lacking the Redox Master Regulator Nrf2 or Its Target Gene Heme Oxygenase-1

  2010cited by this paper
• Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease.

  2010cited by this paper
• Three-dimensional elemental bio-imaging of Fe, Zn, Cu, Mn and P in a 6-hydroxydopamine lesioned mouse brain.

  2010cited by this paper
• Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration.

  2010cited by this paper
• Rg1 protects iron‐induced neurotoxicity through antioxidant and iron regulatory proteins in 6‐OHDA‐treated MES23.5 cells

  2010cited by this paper
• Copper-Triggered Aggregation of Ubiquitin

  2009cited by this paper
• The role of tau in neurodegeneration

  2009cited by this paper
• Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins.

  2009cited by this paper
• The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson’s disease

  2009cited by this paper
• No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism

  2009cited by this paper
• Restoration of Nigrostriatal Dopamine Neurons in Post-MPTP Treatment by the Novel Multifunctional Brain-Permeable Iron Chelator-Monoamine Oxidase Inhibitor Drug, M30

  2009cited by this paper
• ZnT3 mRNA levels are reduced in Alzheimer's disease post-mortem brain

  2009cited by this paper
• Inhibition of Prolyl Hydroxylase Protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Neurotoxicity

  2009cited by this paper
• Zinc in the physiology and pathology of the CNS

  2009cited by this paper
• Copper reduces striatal protein nitration and tyrosine hydroxylase inactivation induced by MPP+ in rats.

  2009cited by this paper
• Cytosolic labile zinc accumulation in degenerating dopaminergic neurons of mouse brain after MPTP treatment.

  2009cited by this paper
• Quantitative elemental bio-imaging of Mn, Fe, Cu and Zn in 6-hydroxydopamine induced Parkinsonism mouse models

  2009cited by this paper
• Disturbance of iron metabolism in Parkinson’s disease — ultrasonography as a biomarker

  2009cited by this paper
• Rg 1 protects the MPP þ-treated MES 23 . 5 cells via attenuating DMT 1 up-regulation and cellular iron uptake

  2009cited by this paper
• Acupuncture inhibits ferric iron deposition and ferritin-heavy chain reduction in an MPTP-induced parkinsonism model.

  2009cited by this paper
• Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta.

  2008cited by this paper
• Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY‐5Y cells

  2008cited by this paper
• Mechanism of metal-mediated DNA damage and apoptosis induced by 6-hydroxydopamine in neuroblastoma SH-SY5Y cells

  2008cited by this paper
• Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease

  2008cited by this paper
• Transcranial sonography in movement disorders.

  2008cited by this paper
• Zinc rescues dopaminergic SK-N-SH cell lines from methamphetamine-induced toxicity.

  2008cited by this paper
• Role of Lipoamide Dehydrogenase and Metallothionein on 1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced Neurotoxicity

  2008cited by this paper
• Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators

  2008cited by this paper
• Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol.

  2008cited by this paper
• Role and regulation of ferritin H in rotenone-mediated mitochondrial oxidative stress.

  2008cited by this paper
• Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.

  2008cited by this paper
• Covalent arylation of metallothionein by oxidized dopamine products: A possible mechanism for zinc-mediated enhancement of dopaminergic neuron survival

  2008cited by this paper
• Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6‐OHDA‐lesioned rats

  2007cited by this paper
• Brain ferritin iron may influence age- and gender-related risks of neurodegeneration.

  2007cited by this paper
• 17β-Estradiol reduces nitrotyrosine immunoreactivity and increases SOD1 and SOD2 immunoreactivity in nigral neurons in male mice following MPTP insult

  2007cited by this paper
• Coenzyme Q10 provides neuroprotection in iron-induced apoptosis in dopaminergic neurons

  2007cited by this paper
• Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age.

  2007cited by this paper
• Functional Consequences of Iron Overload in Catecholaminergic Interactions: the Youdim Factor

  2007cited by this paper
• Gene expression profiling of MPP+-treated MN9D cells: a mechanism of toxicity study.

  2007cited by this paper
• Protocol for the MPTP mouse model of Parkinson's disease

  2007cited by this paper
• Iron trafficking inside the brain

  2007cited by this paper
• Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration.

  2007cited by this paper
• Manganese does not alter the severe neurotoxicity of MPTP

  2007cited by this paper
• Copper ions disrupt dopamine metabolism via inhibition of V‐H+‐ATPase: a possible contributing factor to neurotoxicity

  2007cited by this paper
• Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

  2007cited by this paper
• The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in mice

  2007cited by this paper
• Selegiline slows the progression of the symptoms of Parkinson disease

  2006cited by this paper
• Epidemiology of Parkinson's disease.

  2006cited by this paper
• Imidaprilat suppresses nonylphenol and 1-methyl-4-phenylpyridinium ion (MPP+)-induced hydroxyl radical generation in rat striatum.

  2006cited by this paper
• Effect of desferrioxamine, a strong iron (III) chelator, on 1-methyl-4-phenylpyridinium ion (MPP+)-induced hydroxyl radical generation in the rat striatum.

  2006cited by this paper
• Iron metabolism in Parkinsonian syndromes

  2006cited by this paper
• Metal specificity of an iron-responsive element in Alzheimer's APP mRNA 5'untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator.

  2006cited by this paper
• Oxidative stress and brain aging: is zinc the link?

  2006cited by this paper
• Altered Gene Expression Profiles Reveal Similarities and Differences Between Parkinson Disease and Model Systems

  2005cited by this paper
• Metallothionein provides zinc-mediated protective effects against methamphetamine toxicity in SK-N-SH cells.

  2005cited by this paper
• Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice

  2005cited by this paper
• Superoxide Dismutase/Catalase Mimetics Are Neuroprotective against Selective Paraquat-mediated Dopaminergic Neuron Death in the Substantial Nigra

  2005cited by this paper
• Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease.

  2005cited by this paper
• Excessive iron accumulation in the brain: A possible potential risk of neurodegeneration in Parkinson's disease

  2005cited by this paper
• Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms

  2005cited by this paper
• Novel multifunctional neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP‐induced striatal dopamine depletion

  2005cited by this paper
• Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration.

  2005cited by this paper
• Reduction of zinc-positive terminal fields in striatum of mouse after 1-methyl-4-phenylpyridinium neurotoxicity.

  2005cited by this paper
• Oxidative stress and inflammation in Parkinson's disease: is there a causal link?

  2005cited by this paper
• Copper, oxidative stress, and human health.

  2005cited by this paper
• Metals in our minds: therapeutic implications for neurodegenerative disorders.

  2004cited by this paper
• Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease.

  2004cited by this paper
• Role of dietary iron restriction in a mouse model of Parkinson's disease.

  2004cited by this paper
• A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation.

  2004cited by this paper
• The Metabolism of Neuronal Iron and Its Pathogenic Role in Neurological Disease: Review

  2004cited by this paper
• Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease.

  2004cited by this paper
• The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging.

  2004cited by this paper
• Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats.

  2004cited by this paper
• Neuroprotective Effect of Acute and Chronic Administration of Copper (II) Sulfate against MPP+ Neurotoxicity in Mice

  2004cited by this paper
• Iron, brain ageing and neurodegenerative disorders

  2004cited by this paper
• MPTP as a Mitochondrial Neurotoxic Model of Parkinson's Disease

  2004cited by this paper
• Oxidative stress in neurodegeneration: cause or consequence?

  2004cited by this paper

• Nanotechnology-Based Advancements in Parkinson's Therapy: Exploring Animal Models and Clinical Insights in Neurodegenerative Disorders.

  2026cites this paper
• Therapeutic Potential of KATP Channels in the Attenuation of Parkinson's Disease Pathogenesis and Progression - A Review.

  2025cites this paper
• Tiny Fish, Big Hope: Zebrafish Unlocking Secrets to Fight Parkinson’s Disease

  2025cites this paper
• Unraveling Parkinson's disease: The mystery of mitochondria and the role of aging

  2025cites this paper
• Evaluation of novel selective MAO-B inhibitors using immobilized enzymes on magnetic beads.

  2025cites this paper
• Melatonin attenuates MPP+-induced autophagy via heat shock protein in the Parkinson’s disease mouse model

  2025cites this paper
• Induction of Ferroptotic Cell Death by Neuromelanin Pigments in Dopaminergic Cells

  2025cites this paper
• A new strategy for the treatment of Parkinson's disease: Discovery and bio-evaluation of the first central-targeting tyrosinase inhibitor.

  2024cites this paper
• RNA sequencing and proteomic profiling reveal alterations by MPTP in chronic stomach mucosal injury in tree shrew Chinese (Tupaia belangeri chinensis)

  2024cites this paper
• From the Gut to the Brain: The Role of Enteric Glial Cells and Their Involvement in the Pathogenesis of Parkinson’s Disease

  2024cites this paper
• Neuroinflammation-induced neurodegeneration and associated microglia activation in Parkinson’s disease: a novel neurotherapeutic avenue

  2024cites this paper
• Coumarin-chalcone derivatives as dual NLRP1 and NLRP3 inflammasome inhibitors targeting oxidative stress and inflammation in neurotoxin-induced HMC3 and BE(2)-M17 cell models of Parkinson's disease

  2024cites this paper
• HMGA1 Regulates IRS2 to Promote Inflammatory Responses and Oxidative Stress Injury in MPP+-Induced cells

  2024cites this paper
• Nigrostriatal inflammation is associated with nonmotor symptoms in an experimental model of prodromal Parkinson's disease.

  2024cites this paper
• Design and Synthesis of Novel Thiazole Linked Tetrahydropyridine Analogues as Anticancer Agents

  2024cites this paper
• Study of Drug Delivery Using Purely Organic Macrocyclic Containers—Cucurbit[7]uril and Pillararene

  2023cites this paper
• Smart antioxidant function enhancing (SAFE) nucleic acid therapy for ROS-related chronic diseases and comorbidities

  2023cites this paper
• Repurposing Simvastatin in Parkinson’s Disease Model: Protection Is throughout Modulation of the Neuro-Inflammatory Response in the Substantia nigra

  2023cites this paper
• Quantitative Determination of Endogenous Tetrahydroisoquinolines, Potential Parkinson's Disease Biomarkers, in Mammals.

  2022cites this paper
• A brief history of brain iron accumulation in Parkinson disease and related disorders

  2022cites this paper
• Brain pathological changes during neurodegenerative diseases and their identification methods: How does QSM perform in detecting this process?

  2022cites this paper
• Quercetin rescues MPP+ –induced Parkinsonian-like locomotor impairment in zebrafish larvae

  2022cites this paper
• The C-terminal domain of the heavy chain of tetanus toxin prevents the oxidative and nitrosative stress induced by acute toxicity of 1-methyl-4-phenylpyridinium, a rat model of Parkinson's disease.

  2021cites this paper
• Laser Ablation-Inductively Coupled Plasma-Mass Spectrometry Imaging in Biology.

  2021cites this paper
• Sirtuins in mechanistic target of rapamycin complex 1 signaling

  2021cites this paper
• Serum Ceruloplasmin Depletion is Associated With Magnetic Resonance Evidence of Widespread Accumulation of Brain Iron in Parkinson's Disease

  2021cites this paper
• Long non‐coding RNA MALAT1 regulates cell proliferation and apoptosis via miR-135b-5p/GPNMB axis in Parkinson’s disease cell model

  2021cites this paper
• Pramipexole attenuates neuronal injury in Parkinson's disease by targeting miR-96 to activate BNIP3-mediated mitophagy.

  2021cites this paper
• Intranasal administration of α-synuclein preformed fibrils triggers microglial iron deposition in the substantia nigra of Macaca fascicularis

  2021cites this paper
• Cerebroventricular Microinjections of MPTP on Adult Zebrafish Induces Dopaminergic Neuronal Death, Mitochondrial Fragmentation, and Sensorimotor Impairments

  2021cites this paper
• Dynamic changes of activated AHR in microglia and astrocytes in the substantia nigra-striatum system in an MPTP-induced Parkinson's disease mouse model.

  2021cites this paper
• Alpha-Lipoic Acid Mediates Clearance of Iron Accumulation by Regulating Iron Metabolism in a Parkinson’s Disease Model Induced by 6-OHDA

  2020cites this paper
• Air pollutants disrupt iron homeostasis to impact oxidant generation, biological effects, and tissue injury.

  2020cites this paper
• Life, death, and regeneration of zebrafish dopaminergic neurons

  2020cites this paper
• LINC00943 knockdown attenuates MPP+-induced neuronal damage via miR-15b-5p/RAB3IP axis in SK-N-SH cells

  2020cites this paper
• Sex differences in the progressive model of parkinsonism induced by reserpine in rats

  2019cites this paper
• l‐3,4‐dihydroxyphenylalanine (l‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's disease

  2019cites this paper
• Comprehensive Analysis of Neurotoxin-Induced Ablation of Dopaminergic Neurons in Zebrafish Larvae

  2019influential citation
• Pramipexole Inhibits MPP+-Induced Neurotoxicity by miR-494-3p/BDNF

  2019cites this paper
• Retracted Article: LncRNA MALAT1 aggravates MPP-induced neuronal injury by regulating miR-212 in SH-SY5Y cells

  2019cites this paper
• Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping

  2019cites this paper
• From niche methods to necessary tools: The growing importance of analytical atomic spectrometry in metal imaging in neuroscience

  2019cites this paper
• Design, synthesis and biological evaluation of 2-(3,4-dimethoxyphenyl)-6 (1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyridine analogues as antiproliferative agents.

  2019cites this paper
• Melatonin: A Versatile Protector against Oxidative DNA Damage

  2018cites this paper
• Advances in the Chemical Biology of Desferrioxamine B.

  2017cites this paper
• Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson’s disease

  2017cites this paper
• Catechol Tetrahydroisoquinolines Enhance a-Synuclein Aggregation andSpecify the Neurotoxicity to Dopaminergic Neurons

  2017cites this paper
• Analogues of desferrioxamine B designed to attenuate iron-mediated neurodegeneration: synthesis, characterisation and activity in the MPTP-mouse model of Parkinson's disease.

  2017cites this paper
• Sirtuins as modifiers of Parkinson's disease pathology

  2017cites this paper
• Not all boronic acids with a five‐membered cycle induce tremor, neuronal damage and decreased dopamine

  2017cites this paper
• Brain Iron Metabolism Dysfunction in Parkinson’s Disease

  2017cites this paper
• Copper sulfate pretreatment prevents mitochondrial electron transport chain damage and apoptosis against MPP+-induced neurotoxicity.

  2017cites this paper
• Neuroprotective effects of α‐melanocyte‐stimulating hormone against the neurotoxicity of 1‐methyl‐4‐phenylpyridinium

  2017cites this paper
• The Role of Selenium in Neurodegenerative Diseases

  2017cites this paper
• Imaging Metals in the Brain by Laser Ablation–Inductively Coupled Plasma-Mass Spectrometry

  2017cites this paper
• Selenotranscriptomic Analyses Identify Signature Selenoproteins in Brain Regions in a Mouse Model of Parkinson’s Disease

  2016cites this paper
• Iron and dopamine: a toxic couple.

  2016cites this paper
• Clioquinol Improves Cognitive, Motor Function, and Microanatomy of the Alpha-Synuclein hA53T Transgenic Mice.

  2016cites this paper
• Effects of Neonatal Iron Feeding and Chronic Clioquinol Administration on the Parkinsonian Human A53T Transgenic Mouse.

  2016cites this paper
• Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System

  2016cites this paper
• Noradrenergic-Dopaminergic Interactions Due to DSP-4-MPTP Neurotoxin Treatments: Iron Connection.

  2016cites this paper
• On the outside looking in: redefining the role of analytical chemistry in the biosciences.

  2016cites this paper
• Supramolecular Inhibition of Neurodegeneration by a Synthetic Receptor.

  2015cites this paper
• Are Striatal Tyrosine Hydroxylase Interneurons Dopaminergic?

  2015influential citation
• Capstone Course

  2015cites this paper
• Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral α-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys.

  2015cites this paper
• Intracranial Glioblastomas: New Hope for an Effective Treatment

  2015cites this paper
• Using Tinbergen's Four Questions as the Framework for a Neuroscience Capstone Course.

  2015cites this paper
• Zebrafish as a translational model of Parkinson's disease : a study of microRNAs

  2015cites this paper
• Selenium, selenoproteins and neurodegenerative diseases.

  2015cites this paper
• The effect of paraformaldehyde fixation and sucrose cryoprotection on metal concentration in murine neurological tissue

  2014cites this paper
• The role of iron in brain ageing and neurodegenerative disorders.

  2014cites this paper
• Angiotensin II Inhibits Iron Uptake and Release in Cultured Neurons

  2014cites this paper
• MRI assessment of brain iron content in methamphetamine users

  2014cites this paper
• An iron–dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta

  2014cites this paper
• Ligand Design to Target and Modulate Metal–Protein Interactions in Neurodegenerative Diseases

  2014cites this paper
• A delicate balance: Iron metabolism and diseases of the brain

  2013cites this paper